跳至主要内容
临床试验/IRCT20121216011763N42
IRCT20121216011763N42招募中未知

The effect of Curcumin-Piperine supplementation on cardiometabolic factors, hepatic steatosis and fibrosis of fibroscan results and liver function in patients with non-alcoholic fatty liver disease: a randomized double-blind clinical trial

Esfahan University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Tendency to participate in the study
  • People aged 18-65 years
  • Patients with Non-alcoholic fatty liver (grade 3-1) diagnosed by ultrasound

排除标准

  • Pregnancy and lactation
  • Patients with Alcoholic Fatty Liver
  • People with heart , pulmonary and kidney diseases, hepatitis, cirrhosis, biliary and immune disorders, hypertension, diabetes, hypothyroidism and Cushing's syndrome
  • Consumption of lipid and glucose lowering medicine, Vitamin E, Vitamin D, Orsodeoxycholic acid, Phenytoin, Tamoxifen, Lithium, Corticosteroids and Methotrexate
  • Weight loss and bariatric surgery in the last year

研究者

相似试验